DE60110814D1 - Zusammensetzungen mit langsamer freigabe enthaltend lithium-carbonat - Google Patents

Zusammensetzungen mit langsamer freigabe enthaltend lithium-carbonat

Info

Publication number
DE60110814D1
DE60110814D1 DE60110814T DE60110814T DE60110814D1 DE 60110814 D1 DE60110814 D1 DE 60110814D1 DE 60110814 T DE60110814 T DE 60110814T DE 60110814 T DE60110814 T DE 60110814T DE 60110814 D1 DE60110814 D1 DE 60110814D1
Authority
DE
Germany
Prior art keywords
lithium carbonate
containing lithium
compositions
slow release
release containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60110814T
Other languages
English (en)
Inventor
Giulio Tarro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noven Therapeutics LLC
Original Assignee
JDS Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2000MI001868A external-priority patent/IT1318677B1/it
Priority claimed from ITMI20010299 external-priority patent/ITMI20010299A1/it
Application filed by JDS Pharmaceuticals LLC filed Critical JDS Pharmaceuticals LLC
Application granted granted Critical
Publication of DE60110814D1 publication Critical patent/DE60110814D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
DE60110814T 2000-08-10 2001-08-06 Zusammensetzungen mit langsamer freigabe enthaltend lithium-carbonat Expired - Lifetime DE60110814D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2000MI001868A IT1318677B1 (it) 2000-08-10 2000-08-10 Composizione farmaceutica contenente litio carbonato.
ITMI20010299 ITMI20010299A1 (it) 2001-02-14 2001-02-14 Composizione farmaceutica contenente litio carbonato
PCT/EP2001/009054 WO2002011740A2 (en) 2000-08-10 2001-08-06 'slow release' pharmaceutical compositions comprising lithium carbonate

Publications (1)

Publication Number Publication Date
DE60110814D1 true DE60110814D1 (de) 2005-06-16

Family

ID=26332755

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60110814T Expired - Lifetime DE60110814D1 (de) 2000-08-10 2001-08-06 Zusammensetzungen mit langsamer freigabe enthaltend lithium-carbonat

Country Status (11)

Country Link
US (3) US6989159B2 (de)
EP (1) EP1315480B1 (de)
JP (1) JP2004505923A (de)
CN (1) CN1230150C (de)
AT (1) ATE295154T1 (de)
AU (1) AU2001291738A1 (de)
BR (1) BR0113070A (de)
CA (1) CA2417930A1 (de)
DE (1) DE60110814D1 (de)
EA (1) EA200300128A1 (de)
WO (1) WO2002011740A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010220A1 (it) * 2001-02-05 2002-08-05 Valpharma Sa Formulazioni multiparticolate per somministrazione orale di sali di litio idonee per una somministrazione al giorno
US20040241252A1 (en) * 2003-05-29 2004-12-02 Abney Christopher Charles Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same
WO2005102366A2 (en) * 2004-04-19 2005-11-03 Philip Maxwell Satow Lithium combinations, and uses related thereto
WO2008022472A1 (de) * 2006-08-23 2008-02-28 Heinz Forster Pharmazeutische zusammensetzung
WO2008067409A2 (en) * 2006-11-28 2008-06-05 Polyplus Battery Company Protected lithium electrodes for electro-transport drug delivery
US20090005824A1 (en) * 2007-06-29 2009-01-01 Polyplus Battery Company Electrotransport devices, methods and drug electrode assemblies
US20090069740A1 (en) * 2007-09-07 2009-03-12 Polyplus Battery Company Protected donor electrodes for electro-transport drug delivery
FR2999426B1 (fr) * 2012-12-13 2015-01-02 Flamel Tech Sa Forme orale multiparticulaire a liberation immediate d'au moins un compose actif, comprenant des particules enrobees resistantes au broyage.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016922B (en) * 1978-02-17 1982-08-18 Delandale Lab Ltd Sustained release lithium carbonate tables
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
SE509029C2 (sv) 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
WO1999017751A1 (en) * 1997-10-03 1999-04-15 Smithkline Beecham Corporation Controlled release solid dosage forms of lithium carbonate

Also Published As

Publication number Publication date
EP1315480B1 (de) 2005-05-11
JP2004505923A (ja) 2004-02-26
WO2002011740A2 (en) 2002-02-14
US20050208154A1 (en) 2005-09-22
CA2417930A1 (en) 2002-02-14
US20080124390A1 (en) 2008-05-29
US20040013746A1 (en) 2004-01-22
US6989159B2 (en) 2006-01-24
CN1446082A (zh) 2003-10-01
AU2001291738A1 (en) 2002-02-18
ATE295154T1 (de) 2005-05-15
EP1315480A2 (de) 2003-06-04
WO2002011740A3 (en) 2002-04-18
CN1230150C (zh) 2005-12-07
BR0113070A (pt) 2003-07-08
EA200300128A1 (ru) 2003-08-28

Similar Documents

Publication Publication Date Title
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
RS50510B (sr) Formulacije koje sadrže ekteinascidin i disaharid
DE60043447D1 (de) Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid
DE69907977D1 (de) Pyrrolobenzodiazepine
DE60042904D1 (de) Orale Dosiszusammensetzung mit verlängerter Freigabe
DE60118496D1 (de) Pulverzusammensetzung
FR2810237B1 (fr) Composition cosmetique filmogene
FR2815851B1 (fr) Composition cosmetique filmogene
BR0106649B1 (pt) composição fertilizante contendo enxofre.
HRP20030154B1 (en) Preparation of risperidone
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
PT1086701E (pt) Composicao laxante contendo simeticone
DE60023107D1 (de) Zubereitungen mit verbesserter kontrollierter freisetzung
FR2810238B1 (fr) Composition cosmetique filmogene
FR2814673B1 (fr) Composition cosmetique filmogene
DE69925167D1 (de) Hochwitterungsbeständige pulverlackzusammensetzung
FR2810236B1 (fr) Composition cosmetique filmogene
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
FR2810239B1 (fr) Composition cosmetique filmogene
DE60112756D1 (de) Racecadotril enthaltende trockene pulverformulierung
DE60045012D1 (de) Filmbildende zusammensetzung mit oktylbenzoat
DE60110814D1 (de) Zusammensetzungen mit langsamer freigabe enthaltend lithium-carbonat
NO20030536L (no) Polymer elektrolyttsammensetning
SE9903290D0 (sv) Novel compounds
ATE412405T1 (de) Pharmazeutische zusammensetzung mit modifiziertem träger